SEC Form 4 · accession 0001061983-16-000041
CYTOKINETICS INC · CYTK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bradley Paul Morgan
Officer — SVP Drug Discovery & Early Dev
Period of report
Mar 15, 2006
Accepted (ET)
Feb 25, 2016 · 6:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001061983
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F1 | $6.00 | Mar 5, 2013 | A | 21,204 | A | Apr 5, 2013 | Mar 5, 2023 | Common Stock | 21,204 | 21,204 | D |
| Incentive Stock Option (right to buy)F2 | $6.30 | Mar 5, 2012 | A | 13,920 | A | Apr 5, 2012 | Mar 5, 2022 | Common Stock | 13,920 | 13,920 | D |
| Incentive Stock Option (right to buy)F3 | $6.67 | Feb 23, 2016 | A | 18,817 | A | Mar 23, 2016 | Feb 23, 2026 | Common Stock | 18,817 | 18,817 | D |
| Incentive Stock Option (right to buy)F4 | $7.96 | Feb 26, 2015 | A | 11,044 | A | Mar 26, 2015 | Feb 26, 2025 | Common Stock | 11,044 | 11,044 | D |
| Incentive Stock Option (right to buy)F5 | $9.42 | Feb 28, 2011 | A | 11,883 | A | Mar 28, 2011 | Feb 28, 2021 | Common Stock | 11,883 | 11,883 | D |
| Incentive Stock Option (right to buy)F6 | $9.65 | Feb 24, 2014 | A | 18,448 | A | Mar 24, 2014 | Feb 24, 2024 | Common Stock | 18,448 | 18,448 | D |
| Incentive Stock Option (right to buy)F7 | $11.10 | Feb 26, 2009 | A | 2,638 | A | Mar 26, 2009 | Feb 26, 2019 | Common Stock | 2,638 | 2,638 | D |
| Incentive Stock Option (right to buy)F7 | $11.10 | Feb 26, 2009 | A | 2,639 | A | Mar 26, 2009 | Feb 26, 2019 | Common Stock | 2,639 | 5,277 | D |
| Incentive Stock Option (right to buy)F8 | $18.48 | Feb 24, 2010 | A | 3,333 | A | Mar 24, 2010 | Feb 24, 2020 | Common Stock | 3,333 | 3,333 | D |
| Incentive Stock Option (right to buy)F9 | $18.48 | Feb 24, 2010 | A | 4,278 | A | Mar 24, 2010 | Feb 24, 2020 | Common Stock | 4,278 | 7,611 | D |
| Incentive Stock Option (right to buy)F10 | $20.22 | Feb 29, 2008 | A | 2,101 | A | Mar 29, 2008 | Feb 28, 2018 | Common Stock | 2,101 | 2,101 | D |
| Incentive Stock Option (right to buy)F11 | $40.86 | Mar 14, 2007 | A | 3,106 | A | Apr 14, 2007 | Mar 14, 2017 | Common Stock | 3,106 | 3,106 | D |
| Incentive Stock Option (right to buy)F12 | $42.24 | Mar 15, 2006 | A | 5,000 | A | Apr 1, 2006 | Mar 15, 2016 | Common Stock | 5,000 | 5,000 | D |
| Non-Qualified Stock Option (right to buy)F1 | $6.00 | Mar 5, 2013 | A | 3,795 | A | Apr 5, 2013 | Mar 5, 2023 | Common Stock | 3,795 | 3,795 | D |
| Non-Qualified Stock Option (right to buy)F2 | $6.30 | Mar 5, 2012 | A | 1,079 | A | Apr 5, 2012 | Mar 5, 2022 | Common Stock | 1,079 | 1,079 | D |
| Non-Qualified Stock Option (right to buy)F3 | $6.67 | Feb 23, 2016 | A | 31,183 | A | Mar 23, 2016 | Feb 23, 2026 | Common Stock | 31,183 | 31,183 | D |
| Non-Qualified Stock Option (right to buy)F4 | $7.96 | Feb 26, 2015 | A | 18,956 | A | Mar 26, 2015 | Feb 26, 2025 | Common Stock | 18,956 | 18,956 | D |
| Non-Qualified Stock Option (right to buy)F5 | $9.42 | Feb 28, 2011 | A | 617 | A | Mar 28, 2011 | Feb 28, 2021 | Common Stock | 617 | 617 | D |
| Non-Qualified Stock Option (right to buy)F6 | $9.65 | Feb 24, 2014 | A | 11,552 | A | Mar 24, 2014 | Feb 24, 2024 | Common Stock | 11,552 | 11,552 | D |
| Non-Qualified Stock Option (right to buy)F7 | $11.10 | Feb 26, 2009 | A | 695 | A | Mar 26, 2009 | Feb 26, 2019 | Common Stock | 695 | 695 | D |
| Non-Qualified Stock Option (right to buy)F7 | $11.10 | Feb 26, 2009 | A | 694 | A | Mar 26, 2009 | Feb 26, 2019 | Common Stock | 694 | 1,389 | D |
| Non-Qualified Stock Option (right to buy)F9 | $18.48 | Feb 24, 2010 | A | 721 | A | Mar 24, 2010 | Feb 24, 2020 | Common Stock | 721 | 721 | D |
| Non-Qualified Stock Option (right to buy)F10 | $20.22 | Feb 29, 2008 | A | 1,033 | A | Mar 29, 2008 | Feb 28, 2018 | Common Stock | 1,033 | 1,033 | D |
| Non-Qualified Stock Option (right to buy)F11 | $40.86 | Mar 14, 2007 | A | 193 | A | Apr 14, 2007 | Mar 14, 2017 | Common Stock | 193 | 193 | D |
Explanation of responses
- F1When the ISO and NQ dated 03/05/2013 are combined for a total grant of 24,999 shares, the option shall vest and become exercisable as to 520 shares on 04/05/2013 and the balance of 24,479 divided into equal monthly installments thereafter such that the option shall be 100% vested on 03/05/2017.
- F10When the ISO and NQ dated 02/29/2008 are combined for a total grant of 3,134 shares, the option shall vest and become exercisable as to 65 shares on 03/29/08 and the balance of 3,069 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/29/12.
- F11When the ISO and NQ dated 03/14/2007 are combined for a total grant of 3,299 shares, the option shall vest and become exercisable as to 68 shares on 04/01/07 and the balance of 3,231 divided into equal monthly installments thereafter such that the option shall be 100% vested on 03/01/11.
- F12This option shall vest and become exercisable as to 104 shares on 04/01/06 and the balance of 4,896 divided into equal monthly installments thereafter such that the option shall be 100% vested on 03/01/10.
- F2When the ISO and NQ dated 03/05/2012 are combined for a total grant of 14,999 shares, the option shall vest and become exercisable as to 312 shares on 04/05/2012 and the balance of 14,687 divided into equal monthly installments thereafter such that the option shall be 100% vested on 03/05/2016.
- F3When the ISO and NQ dated 02/23/2016 are combined for a total grant of 50,000 shares, the option shall vest and become exercisable as to 50,000 shares divided into equal monthly installments such that the option shall be 100% vested on 02/23/2020.
- F4When the ISO and NQ dated 02/26/2015 are combined for a total grant of 30,000 shares, the option shall vest and become exercisable as to 625 shares on 03/26/2015 and the balance of 29,375 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/26/2019.
- F5When the ISO and NQ dated 02/28/2011 are combined for a total grant of 12,500 shares, the option shall vest and become exercisable as to 260 shares on 03/31/2011 and the balance of 12,240 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/28/2015.
- F6When the ISO and NQ dated 02/24/2014 are combined for a total grant of 30,000 shares, the option shall vest and become exercisable as to 625 shares on 03/24/2014 and the balance of 29,375 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/24/2018.
- F7When the ISO and NQ's dated 02/26/2009 are combined for a total grant of 6,666 shares, the option shall vest and become exercisable as to 138 shares on 03/26/09 and the balance of 6,528 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/26/13.
- F8This option shall vest and become exercisable as to 69 shares on 03/24/10 and the balance of 3,264 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/24/14.
- F9When the ISO and NQ dated 02/24/2010 are combined for a total grant of 4,999 shares, the option shall vest and become exercisable as to 104 shares on 03/24/2010 and the balance of 4,895 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/24/2014.